• 1
    Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007; 370: 851-858.
  • 2
    Katon W. The impact of major depression on chronic medical illness. Gen Hosp Psychiatry. 1996; 18: 215-219.
  • 3
    Derogatis LR, Morrow GR, Fetting J, et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983; 249: 751-757.
  • 4
    Ell K, Sanchez K, Vourlekis B, et al. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol. 2005; 23: 3052-3060.
  • 5
    Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 2001; 84: 1011-1015.
  • 6
    Sharpe M, Strong V, Allen K, et al. Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer. 2004; 90: 314-320.
  • 7
    National Institute for Health and Clinical Excellence. Management of depression in primary and secondary care. Bethesda, Md: National Institute for Health and Clinical Excellence; 2007. 1-4-2007. Accessed January 9, 2009.
  • 8
    U.S. Preventive Services Task Force. Screening for depression in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 151: 784-792.
  • 9
    Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999; 282: 1737-1734.
  • 10
    Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med. 2007; 22: 1596-1602.
  • 11
    Wittkampf KA, Naeije L, Schene AH, Huyser J, van Weert HC. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review. Gen Hosp Psychiatry. 2007; 29: 388-395.
  • 12
    Williams JWJr, Pignone M, Ramirez G, Perez SC. Identifying depression in primary care: a literature synthesis of case-finding instruments. Gen Hosp Psychiatry. 2002; 24: 225-237.
  • 13
    Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 2009; 101: 1464-1488.
  • 14
    Ormel J, Vonkorff M, Ustun TB, Pini S, Korten A, Oldehinkel T. Common mental disorders and disability across cultures: results from the WHO collaborative study on psychological problems in general health care. JAMA. 1994; 272: 1741-1748.
  • 15
    Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67: 361-370.
  • 16
    Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer. 1994; 30: 37-40.
  • 17
    Walker J, Postma K, McHugh GS, et al. Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. J Psychosom Res. 2007; 63: 83-91.
  • 18
    Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry. 1992; 49: 624-629.
  • 19
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
  • 20
    Chochinov HM, Wilson KG, Enns M, Lander S. Prevalence of depression in the terminally ill: effects of diagnostic criteria and symptom threshold judgments. Am J Psychiatry. 1994; 151: 537-540.
  • 21
    Allen K, Cull A, Sharpe M. Diagnosing major depression in medical outpatients: acceptability of telephone interviews. J Psychosom Res. 2003; 55: 385-387.
  • 22
    Cacciola JS, Alterman AI, Rutherford MJ, McKay JR, May DJ. Comparability of telephone and in-person Structured Clinical Interview for DSM-III-R (SCID) diagnoses. Assessment. 1999; 6: 235-242.
  • 23
    Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606-613.
  • 24
    Lowe B, Spitzer RL, Grafe K, et al. Comparative validity of 3 screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord. 2004; 78: 131-140.
  • 25
    Storey DJ, Waters RA, Hibberd CJ, et al. Clinically relevant fatigue in cancer outpatients: the Edinburgh Cancer Centre symptom study. Ann Oncol. 2007; 18: 1861-1869.
  • 26
    Lamers F, Jonkers CC, Bosma H, Penninx BW, Knottnerus JA, van Eijk JT. Summed score of the Patient Health Questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patients. J Clin Epidemiol. 2008; 61: 679-687.
  • 27
    Fann JR, Berry DL, Wolpin S, et al. Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer. Psychooncology. 2009; 18: 14-22.
  • 28
    Kroenke K, Theobald D, Norton K, et al. The Indiana Cancer Pain and Depression (INCPAD) trial. Design of a telecare management intervention for cancer-related symptoms and baseline characteristics of study participants. Gen Hosp Psychiatry. 2009; 31: 240-253.
  • 29
    Kroenke K, Strine TW, Spitzer RL, Williams JBW, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009; 114: 163-173.
  • 30
    Strong V, Waters R, Hibberd C, et al. Management of depression for people with cancer (SMaRT Oncology 1): a randomised trial. Lancet. 2008; 372: 40-48.
  • 31
    Diez-Quevedo C, Rangil T, Sanchez-Planell L, Kroenke K, Spitzer RL. Validation and utility of the Patient Health Questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients. Psychosom Med. 2001; 63: 679-686.
  • 32
    Becker S, Al Zaid K, Al Faris E. Screening for somatization and depression in Saudi Arabia: a validation study of the PHQ in primary care. Int J Psychiatry Med. 2002; 32: 271-283.
  • 33
    Mazzotti E, Fassone G, Picardi A, et al. The Patient Health Questionnaire (PHQ) for the screening of psychiatric disorders: a validation study versus the Structured Clinical Interview for DSM-IV Axis I (SCID-I). Ital J Psychopathol. 2003; 9: 235-242.
  • 34
    Henkel V, Mergl R, Kohnen R, Allgaier AK, Moller HJ, Hegerl U. Use of brief depression screening tools in primary care: consideration of heterogeneity in performance in different patient groups. Gen Hosp Psychiatry. 2004; 26: 190-198.
  • 35
    Grafe K, Zipfel S, Herzog W, Lowe B. Screening for psychiatric disorders with the Patient Health Questionnaire (PHQ). Results from the German validation study. Diagnostica. 2004; 50: 171-181.
  • 36
    McManus D, Pipkin SS, Whooley MA. Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). Am J Cardiol. 2005; 96: 1076-1081.
  • 37
    Williams LS, Brizendine EJ, Plue L, et al. Performance of the PHQ-9 as a screening tool for depression after stroke. Stroke. 2005; 36: 635-638.
  • 38
    Fann JR, Bombardier CH, Dikmen S, et al. Validity of the Patient Health Questionnaire-9 in assessing depression after traumatic brain injury. J Head Trauma Rehabil. 2005; 20: 501-511.
  • 39
    Picardi A, Adler DA, Abeni D, et al. Screening for depressive disorders in patients with skin diseases: a comparison of 3 screeners. Acta Derm Venereol. 2005; 85: 414-419.
  • 40
    Stafford L, Berk M, Jackson HJ. Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease. Gen Hosp Psychiatry. 2007; 29: 417-424.